Player is loading...
steriLux
Marc Spaltenstein, steriLux
Tuesday, Sept. 19, 2017 · 3:07 p.m. · 02m 37s
Embed
Embed code is not allowed
This talk is part of a Private webcast, embeding is not permited.Transcriptions
Note: this content has been automatically generated.
00:00:00
thank you
00:00:02
so every two minutes to some one died you do a surgical site infection
00:00:08
because of the use of monster one instrument to reason is very simple
00:00:13
because because the machine that can still relies uses a lot of water a lot of
00:00:18
electricity but they are also very expensive i use a lot of consumer bills
00:00:25
all this in developing countries uh people lack all these resources
00:00:30
making it them to know not to release their devices
00:00:36
this is why we develop our own still relies are based on ozone n.
00:00:40
u. v. and we that were machine we can do exactly the same
00:00:45
it's stabilisation but we can do it really is only a small amount of water and
00:00:50
a small amount of electricity while reducing the cost by a factor of two five
00:00:58
we are targeting to me just segments the first one
00:01:02
is me the size a hospital in developing countries
00:01:06
but we also working on a another product what is that
00:01:10
will target a small medical offices in western countries
00:01:16
to do all that we have in our management you myself
00:01:21
i graduated from e. p. f. l. in life sciences
00:01:24
but it is also look yeah uh our site you'll also from e. p. f. l. but in mechanical engineering
00:01:31
and the finally michael r. c. f. all that uh graduated
00:01:35
to also from e. p. f. l. but in bioengineering
00:01:39
in our border uh we have max was uh was my former
00:01:43
director when i when i was working on admit tonic
00:01:46
and also always our main investors and we also have in our team then
00:01:52
a highly skilled in engineers that help us to develop a the machine
00:01:59
what we should so far we raised uh since the last three years uh one million
00:02:05
or switch frank we also protected our technology with two
00:02:09
buttons in national phase and we built five machines
00:02:14
and one is currently use income owning but for some of the scope of a clinical trial
00:02:20
and the next steps is a a one million by the end of this year
00:02:25
and uh for next year we will also get the c. e. mark you can start the first says
